Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.685 EUR -0.32% Market Closed
Market Cap: 222.1m EUR

EV/OCF
Enterprise Value to OCF

-11.1
Current
-7.6
Median
5.3
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-11.1
=
Enterprise Value
217.1m EUR
/
Operating Cash Flow
-19.6m EUR
 
FR
Nanobiotix SA
PAR:NANO
Average EV/OCF: 19.7
Negative Multiple: -11.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 663.3
US
Abbvie Inc
NYSE:ABBV
24.2
US
Amgen Inc
NASDAQ:AMGN
16.8
US
Gilead Sciences Inc
NASDAQ:GILD
14.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.4
AU
CSL Ltd
ASX:CSL
28.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -885.1

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A